Publications by authors named "Joseph Kauer"

Claim this Profile
A
Acquired and Selected: Tracking Antigen Escape during T Cell-Redirecting Therapies in Multiple Myeloma.
Joseph Kauer, Niels Weinhold, Marc S Raab

Blood Cancer Discov· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.
Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Joseph Kauer

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.
Jan H Frenking, Xiang Zhou, Kai Rejeski, Vivien Wagner, Patrick Costello, Joseph Kauer

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.
Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, Stefan W Krause, Sabrina Kraus, Joseph Kauer

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma.
Clara Kolbe, Joseph Kauer, Berit Brinkmann, Peter Dreger, Wolfgang Huber

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.
Jan H Frenking, Xiang Zhou, Vivien Wagner, Thomas Hielscher, Joseph Kauer

J Immunother Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta, Ruparoshni Jayabalan, Hannah Briesch, Joseph Kauer

Blood· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.
Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
Joseph Kauer, Emma P Freundt, Anita Schmitt, Niels Weinhold, Elias K Mai

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.
Sandra Sauer, Lennart Hieke, Juliane Brandt, Carsten Müller-Tidow, Anita Schmitt, Joseph Kauer

Transfus Med Hemother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma.
Sandra Sauer, Katharina Kriegsmann, Cathleen Nientiedt, Anita Schmitt, Carsten Müller-Tidow, Joseph Kauer

Transfus Med Hemother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma.
Joseph Kauer, Lilli Sophie Sester, Katharina Kriegsmann, Niels Weinhold, Michael Ober

Hematol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.
Joseph Kauer, Melanie Märklin, Martin Pflügler, Sebastian Hörner, Clemens Hinterleitner

J Cancer Res Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia.
Maddalena Marconato, Joseph Kauer, Helmut R Salih, Melanie Märklin, Jonas S Heitmann

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.
Sebastian Hörner, Moustafa Moustafa-Oglou, Karin Teppert, Ilona Hagelstein, Joseph Kauer

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of CD105 (endoglin) as novel risk marker in CLL.
Sarah M Greiner, Melanie Märklin, Samuel Holzmayer, Kübra Kaban, Sophie Meyer, Joseph Kauer

Ann Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.
Naveen K Mehta, Martin Pfluegler, Kristan Meetze, Bochong Li, Isabelle Sindel, Joseph Kauer

J Immunother Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model.
Nick Seyfried, Can Yurttas, Markus Burkard, Benedikt Oswald, Alexander Tolios, Joseph Kauer

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies.
Joseph Kauer, Fabian Vogt, Ilona Hagelstein, Sebastian Hörner, Melanie Märklin

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestion.
Sebastian Hörner, Michael Ghosh, Joseph Kauer, Philipp Spät, Hans-Georg Rammensee

Biotechnol Bioeng· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
Melanie Märklin, Alexander R Fuchs, Claudia Tandler, Jonas S Heitmann, Helmut R Salih, Joseph Kauer

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.
Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer

EMBO Mol Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML.
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, Lukas Osburg, Helmut R Salih, Joseph Kauer

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma.
Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk

BMJ Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies.
Joseph Kauer, Sebastian Hörner, Lukas Osburg, Stefanie Müller, Melanie Märklin

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis